{
  "trial_id": "NCT01308840",
  "trial_group": "cancer",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, ECOG performance status, histological subtype, prior treatments, tumor KRAS/BRAF status, measurable disease status, organ and marrow function parameters (leukocytes, absolute neutrophil count, platelets, hemoglobin, magnesium, total bilirubin, AST/ALT, creatinine), life expectancy, presence of concurrent malignancy, prior placement of stents or shunts, exclusion criteria compliance (e.g., absence of brain metastases, absence of allergic reactions, absence of preexisting peripheral neuropathy, absence of uncontrolled intercurrent illness, absence of interstitial lung disease, negative tests for HIV/hepatitis, non-pregnant status).",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Eastern Cooperative Oncology Group (ECOG) Performance status",
          "ECOG performance status"
        ],
        [
          "primary tumor site",
          "histological subtype"
        ],
        [
          "metastases",
          "measurable disease status"
        ]
      ],
      "remaining_reference_features": [
        "Sex: Female",
        "Male",
        "Region of Enrollment",
        "Extent of disease"
      ],
      "remaining_candidate_features": [
        "gender",
        "prior treatments",
        "tumor KRAS/BRAF status",
        "organ and marrow function parameters (leukocytes, absolute neutrophil count, platelets, hemoglobin, magnesium, total bilirubin, AST/ALT, creatinine)",
        "life expectancy",
        "presence of concurrent malignancy",
        "prior placement of stents or shunts",
        "exclusion criteria compliance (e.g., absence of brain metastases, absence of allergic reactions, absence of preexisting peripheral neuropathy, absence of uncontrolled intercurrent illness, absence of interstitial lung disease, negative tests for HIV/hepatitis, non-pregnant status)"
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, ECOG performance status, Leukocyte count, Absolute neutrophil count, Platelet count, Hemoglobin level, Magnesium level, Total bilirubin, AST (SGOT), ALT (SGPT), Creatinine level, Creatinine clearance, Prior malignancy status, Prior stent or shunt placement,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Eastern Cooperative Oncology Group (ECOG) Performance status",
          "ECOG performance status"
        ]
      ],
      "remaining_reference_features": [
        "Extent of disease",
        "primary tumor site",
        "metastases"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Leukocyte count",
        "Absolute neutrophil count",
        "Platelet count",
        "Hemoglobin level",
        "Magnesium level",
        "Total bilirubin",
        "AST (SGOT)",
        "ALT (SGPT)",
        "Creatinine level",
        "Creatinine clearance",
        "Prior malignancy status",
        "Prior stent or shunt placement"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, ECOG Performance Status, Histological diagnosis, Tumor Kras and Braf mutation status, Prior chemoembolization or radiation to the liver, Measurable disease, Life expectancy, Leukocytes, Absolute neutrophil count, Platelets, Hemoglobin, Mg, Total bilirubin, AST (SGOT), ALT (SGPT), Creatinine, Creatinine clearance.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Eastern Cooperative Oncology Group (ECOG) Performance status",
          "ECOG Performance Status"
        ]
      ],
      "remaining_reference_features": [
        "Extent of disease",
        "primary tumor site",
        "metastases"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Histological diagnosis",
        "Tumor Kras and Braf mutation status",
        "Prior chemoembolization or radiation to the liver",
        "Measurable disease",
        "Life expectancy",
        "Leukocytes",
        "Absolute neutrophil count",
        "Platelets",
        "Hemoglobin",
        "Mg",
        "Total bilirubin",
        "AST (SGOT)",
        "ALT (SGPT)",
        "Creatinine",
        "Creatinine clearance"
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, ECOG performance status, life expectancy, histological subtype of biliary tract or gallbladder cancer, tumor Kras and Braf mutation status, presence of measurable disease, prior chemoembolization or radiation to the liver, prior malignancy, presence of biliary obstruction, total bilirubin level, leukocyte count, absolute neutrophil count, platelet count, hemoglobin level, magnesium level, AST (SGOT) level, ALT (SGPT) level, creatinine level, creatinine clearance.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Eastern Cooperative Oncology Group (ECOG) Performance status",
          "ECOG performance status"
        ],
        [
          "Extent of disease",
          "presence of measurable disease"
        ],
        [
          "primary tumor site",
          "histological subtype of biliary tract or gallbladder cancer"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Region of Enrollment",
        "metastases"
      ],
      "remaining_candidate_features": [
        "race",
        "ethnicity",
        "life expectancy",
        "tumor Kras and Braf mutation status",
        "prior chemoembolization or radiation to the liver",
        "prior malignancy",
        "presence of biliary obstruction",
        "total bilirubin level",
        "leukocyte count",
        "absolute neutrophil count",
        "platelet count",
        "hemoglobin level",
        "magnesium level",
        "AST (SGOT) level",
        "ALT (SGPT) level",
        "creatinine level",
        "creatinine clearance"
      ]
    }
  }
}